A new high-performance balloon dilatation catheter, designed for use in peripheral angioplasty procedures below the knee, promises more effective treatment of peripheral artery disease (PAD).

The Sterling SL PTA Balloon Dilatation Catheter from Boston Scientific Corporation has been launched in Europe and the USA.

The new catheter is an addition to the company's Sterling family of peripheral angioplasty balloon catheters.

Developed to treat below-the-knee artery disease, the Sterling SL catheter has a low tip profile, high deliverability and rapid deflation time.

"The Sterling SL Balloon Catheter will provide the length options I need to address below-the-knee procedures for patients with peripheral artery disease," said Kenneth Kollmeyer, M.D., Chief of Vascular Surgery, Methodist Dallas Medical Center. "This product offers the same excellent performance I have come to expect from the Sterling family of balloon catheters."

"The Sterling SL Balloon Catheter reflects Boston Scientific's commitment to providing physicians the most complete set of high-performance peripheral intervention devices," said Joe Fitzgerald, Senior Vice President and President of Boston Scientific's Endovascular Unit.

"The Sterling family is the world's best-selling line of low-profile peripheral angioplasty balloon catheters, and this expanded offering will help reinforce its reputation as a preferred solution for physicians treating peripheral vascular lesions."